Pharmaceutical News

RSS

Educational videos in clinical settings increase HPV vaccination rates among adolescents

A study examining the effect of a video educational intervention aimed at increasing HPV vaccinations among adolescents could help the Centers for Disease Control and Prevention meet its goal of getting more eligible adolescents vaccinated against certain cancers and diseases caused by the human papillomavirus (HPV).

16 Jan 2019

New skin patch provides long-acting contraceptive protection

Researchers have developed a new skin patch that uses microneedle technology to deliver a long-acting contraceptive hormone.

14 Jan 2019

New class of sleeping pill preserves ability to wake in response to danger signals

In a trial of one of the main class of prescription sleeping pills, half the participants slept through a fire alarm as loud as someone vacuuming next to their bed. But a newer alternative preserves the ability to wake in response to danger signals, according to a new research.

11 Jan 2019

Clinigen, Accord Healthcare extend exclusive European clinical trial supply agreement

Clinigen Group plc, the global pharmaceutical and services company, announces that its Clinical Trial Service business has extended its exclusive European clinical trial supply agreement with Accord Healthcare. Clinigen is also offering pharma companies an ‘on demand’ service to Accord’s products, a first for the industry.

From Clinigen Group 11 Jan 2019

Pharmacists could significantly reduce ED crowdedness

Incorporating pharmacists with an expanded scope into the community or hospital emergency departments (ED) could significantly reduce ED crowdedness, according to a new study.

10 Jan 2019

New “drug sponge” could reduce chemotherapy side effects

Researchers have developed a 3D polymer sponge that absorbs excess chemotherapy drugs from the bloodstream following treatment.

9 Jan 2019

Researchers find new way to reduce bleeding in patients after bariatric surgery

Rutgers researchers have found a way to reduce bleeding in patients following bariatric surgery.

9 Jan 2019

Certain psychiatric drugs may increase risk of pneumonia

A review of published studies indicates that use of benzodiazepines and benzodiazepine related drug, which are prescribed to treat various psychiatric diseases, may increase the risk of pneumonia.

9 Jan 2019

Caution must be taken while prescribing opioid to tobacco users to prevent addiction

Tobacco is a known risk factor for the misuse of prescription opioids. In addition, concurrent use of opioids and sedative-hypnotics is a risk factor for opioid overdose or addiction.

9 Jan 2019

Drug combination has added benefit for patients with melanoma

The German Institute for Quality and Efficiency in Health Care investigated whether the drug combinations of dabrafenib plus trametinib and of encorafenib plus binimetinib have an added benefit in comparison with the appropriate comparator therapies for patients with melanoma.

9 Jan 2019

Study confirms increased pneumonia risk with prescription opioids

A study led by researchers at Yale University has shown that taking prescribed opioids increases the risk of pneumonia, irrespective of HIV status.

7 Jan 2019

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

The University of Texas MD Anderson Cancer Center and 4D pharma today announced a strategic collaboration to evaluate 4D's live biotherapeutic oncology pipeline across a range of cancer settings.

7 Jan 2019

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Drugs that can cure hepatitis C revolutionized care for millions of Americans living with the deadly liver infection. The drugs came with a steep price tag — one that prompted state Medicaid programs to initially limit access to the medications to only the sickest patients.

4 Jan 2019

Commonly prescribed ADHD drug unlikely to increase cardiovascular risks in children

With more than 1.8 million children in the U.S. being treated annually with drugs for attention deficit hyperactivity disorder, the possibility that such drugs could damage their hearts has been a significant cause of concern for parents and physicians alike.

3 Jan 2019

New medications provide better treatment for alcohol use disorders, chronic pain, mood disorders

Helping people with addictions has become a research passion for Purdue University's Richard van Rijn, who is leading a team to make drug discoveries to support millions around the world dealing with alcohol use disorders, chronic pain and mood disorders.

3 Jan 2019

Alzheimer’s Disease: Learning from the Past, Looking to the Future

An interview with Dr. Lloyd Tran, discussing the major barriers to Alzheimer’s research and development over the past 40 years.

From Alzheimer International Society 3 Jan 2019

Court decision to stop further cuts in 340B reimbursements protects patient care

The Dec. 27 federal court injunction stopping further cuts in 340B reimbursements for Medicare Part B drugs to some participating hospitals is a critical step in preserving the role that academic health centers play in providing HIV, viral hepatitis, and other infectious disease treatment and prevention services to patients who otherwise lack care options.

2 Jan 2019

Sexual function in women with vulva pain improved with oral nerve pain medication

Women with chronic pain or discomfort around the vulva showed improved sexual function with an oral nerve pain medication used to treat pain caused by a previous herpes infection as well as fibromyalgia, according to a Rutgers study.

2 Jan 2019

Study finds wide variation in neuraxial analgesia use in pregnant women across the United States

Pain relief for pregnant women in labor is commonly given in the form of epidural, spinal or combined spinal-epidural blockade, which is collectively referred to as neuraxial analgesia.

31 Dec 2018

Researchers review applications, properties, and pharmacological potentials of rose hip

The genus Rosa from family Rosaceae is one of the most widespread species from the family. One species, rose hip, is known as a good source of different types of micronutrients and phytochemicals such as phenolic acids, tannins, and flavonoids. It is known as a traditional treatment in folk medicine.

28 Dec 2018

Pharmaceutical News

Educational videos in clinical settings increase HPV vaccination rates among adolescents

New skin patch provides long-acting contraceptive protection

New class of sleeping pill preserves ability to wake in response to danger signals

Clinigen, Accord Healthcare extend exclusive European clinical trial supply agreement

Pharmacists could significantly reduce ED crowdedness

New “drug sponge” could reduce chemotherapy side effects

Researchers find new way to reduce bleeding in patients after bariatric surgery

Certain psychiatric drugs may increase risk of pneumonia

Caution must be taken while prescribing opioid to tobacco users to prevent addiction

Drug combination has added benefit for patients with melanoma

Study confirms increased pneumonia risk with prescription opioids

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Commonly prescribed ADHD drug unlikely to increase cardiovascular risks in children

New medications provide better treatment for alcohol use disorders, chronic pain, mood disorders

Alzheimer’s Disease: Learning from the Past, Looking to the Future

Court decision to stop further cuts in 340B reimbursements protects patient care

Sexual function in women with vulva pain improved with oral nerve pain medication

Study finds wide variation in neuraxial analgesia use in pregnant women across the United States

Researchers review applications, properties, and pharmacological potentials of rose hip

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News